Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Formative Research

Date Submitted: Nov 25, 2020
Date Accepted: Oct 8, 2021
Date Submitted to PubMed: Dec 21, 2021

The final, peer-reviewed published version of this preprint can be found here:

Digital mHealth and Virtual Care Use During COVID-19 in 4 Countries: Rapid Landscape Review

Müller A, Cau A, Semakula M, Lodokiyiia P, Abdullahi O, Bullock M, Hayward A, Lester R

Digital mHealth and Virtual Care Use During COVID-19 in 4 Countries: Rapid Landscape Review

JMIR Form Res 2022;6(11):e26041

DOI: 10.2196/26041

PMID: 34932498

PMCID: 9714961

Digital mHealth and Virtual Care Use in Pandemics: A Rapid Landscape Review of Interventions Used Internationally During COVID-19 in 4 Countries

  • Alison Müller; 
  • Alessandro Cau; 
  • Muhammed Semakula; 
  • Peter Lodokiyiia; 
  • Osman Abdullahi; 
  • Miriam Bullock; 
  • Andrew Hayward; 
  • Richard Lester

ABSTRACT

Background:

As a result of the Coronavirus Disease-2019 (COVID-19) pandemic, significantly fewer patients are able to communicate with their health care practitioners (HCPs) as a result of internationally encouraged physical distancing. This has led to an unprecedented rapid expansion of digital tools to provide digitalized virtual care globally, especially mobile phone facilitated health interventions, called mHealth. To help keep abreast of different mHealth and virtual care technologies being used internationally to facilitate patient care and public health during the COVID-19 pandemic we did a rapid investigation of solutions being deployed and considered in 4 countries.

Objective:

To evaluate mHealth, and digital and contact tracing technologies being used in healthcare among 4 countries.

Methods:

This data was procured by accessing a variety of resources including grey literature, government & health organization websites, in addition to contacting our collaborators in Canada, the UK, Rwanda, and Kenya. We specifically requested information regarding various mHealth and virtual care interventions being used to facilitate patient care and public health, such as case contact tracing.

Results:

We identified a variety of technology in Canada, the UK, Rwanda, and Kenya being used for patient care and public health. The afore-mentioned countries are using both video and text-message based platforms to facilitate communication with HCPs (ex. WelTel, Zoom). Nationally-developed contact-tracing apps are provided free to the public, with most of them using Bluetooth-based technology. We identified that often multiple complimentary technologies are being utilized for different aspects of patient care and public health with the common purpose to disseminate information safely.

Conclusions:

Virtual care and mHealth technologies have evolved rapidly as a tool for health care support for both patient care and public health. It is evident that, on an international level, a variety of mHealth and virtual care interventions, often in combination, are required to be able to address patient care and public health concerns during the COVID-19 pandemic. Clinical Trial: N/A


 Citation

Please cite as:

Müller A, Cau A, Semakula M, Lodokiyiia P, Abdullahi O, Bullock M, Hayward A, Lester R

Digital mHealth and Virtual Care Use During COVID-19 in 4 Countries: Rapid Landscape Review

JMIR Form Res 2022;6(11):e26041

DOI: 10.2196/26041

PMID: 34932498

PMCID: 9714961

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.